<DOC>
	<DOCNO>NCT02569866</DOCNO>
	<brief_summary>This study design determine role antibiotic reduction mammaplasty influence surgical site infection rate .</brief_summary>
	<brief_title>Antibiotics After Breast Reduction : Clinical Trial With Randomization</brief_title>
	<detailed_description>Prevention SSI important due morbidity , long hospital stay high cost . In many surgical procedure risk infection relatively low postoperative infection treat properly , role antibiotic clear . Despite lack evidence prospective randomize controlled trial evaluation , use antibiotic plastic surgery widespread order offer high safety standard patient . The breast reduction define `` clean surgery '' low infection rate 3.4 % . Thus , antibiotic recommend . However , study show real rate infection associate procedure range 4-36 % . Thus , trial design verify role antibiotic reduction mammaplasty .</detailed_description>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cephalexin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Breast hypertrophy Body mass index 19 30 kg/m2 Patients undergoing surgical procedure breast Diagnosis breast pathology Smoking Childbirth lactation less year Uncontrolled comorbidities Use immunosuppressive drug Misuse capsule supply Absence weekly followup</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>plastic surgery</keyword>
	<keyword>mammaplasty</keyword>
	<keyword>wound infection</keyword>
	<keyword>prophylaxis</keyword>
</DOC>